Evidence map›Paper›PMID 19805747›Full record

Trial reportThe Journal of physiology2009

Progressive augmentation and ventilatory long-term facilitation are enhanced in sleep apnoea patients and are mitigated by antioxidant administration.

Dorothy S Lee, M Safwan Badr, Jason H Mateika

Open access · greenAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in The Journal of physiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 4 pooled it
1.8field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 4 syntheses or guidelines pooled it, 84 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Drug therapy for obstructive sleep apnoea in adults.The Cochrane database of systematic reviews · 2013
    Pooled it
  5. Trial
  6. Trial
  7. Long-term facilitation of ventilation in humans with chronic spinal cord injury.American journal of respiratory and critical care medicine · 2014
    Trial
  8. Trial
  9. Observational
  10. Article
  11. Article
  12. Advancements in the neurocirculatory reflex response to hypoxia.American journal of physiology. Regulatory, integrative and comparative physiology · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Baseline Arterial COFrontiers in physiology · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Dorothy S LeeJohn D. Dingell Veterans Administration Medical Center, Wayne State University, Detroit, MI 48201, USA.
M Safwan Badr
Jason H Mateika
John D. Dingell VA Medical Center · US

Funding

Impact of intermittent hypoxia on ventilatory drive and apnea severityR01HL085537 · NHLBI · WAYNE STATE UNIVERSITY · PI MATEIKA, JASON H. · 2007 to 2010
$1.5M
NHLBI NIH HHS R01 HL085537NHLBI NIH HHS R01HL085537
6 · The paper itself

Abstract

Progressive augmentation (PA) and ventilatory long-term facilitation (vLTF) of respiratory motor output are forms of respiratory plasticity that are initiated during exposure to intermittent hypoxia. The present study was designed to determine whether PA and vLTF are enhanced in obstructive sleep apnoea (OSA) participants compared to matched healthy controls. The study was also designed to determine whether administration of an antioxidant cocktail mitigates PA and vLTF. Thirteen participants with sleep apnoea and 13 controls completed two trials. During both trials participants were exposed to intermittent hypoxia which included twelve 4-min episodes of hypoxia (P(ETCO(2)), 50 mmHg; P(ETCO(2)), 4 mmHg above baseline) followed by 30 min of recovery. Prior to exposure to intermittent hypoxia, participants were administered, in a randomized fashion, either an antioxidant or a placebo cocktail. Baseline measures of minute ventilation during the placebo and antioxidant trials were not different between or within groups. During the placebo trial, PA was evident in both groups; however it was enhanced in the OSA group compared to control (last hypoxic episode 36.9 +/- 2.8 vs. 27.7 +/- 2.2 l min(-1); P <or= 0.01). Likewise, vLTF was evident during the recovery period in both groups; on the other hand vLTF was greater in the OSA group compared to control (29.3 +/- 2.8 vs. 20.4 +/- 1.3 l min(-1); P <or= 0.01). PA and vLTF were reduced in the OSA group following antioxidant administration compared to the placebo (PA 30.6 +/- 2.0 vs. 36.9 +/- 2.8 l min(-1), P <or= 0.01; vLTF 23.3 +/- 1.4 vs. 29.3 +/- 2.8 l min(-1), P <or= 0.05). We conclude that PA and vLTF are enhanced in participants with OSA and that these forms of respiratory plasticity are mitigated after treatment with an antioxidant cocktail.

Indexed as

AdultAntioxidantsHumansHypoxiaMaleOxidative StressPolysomnographyPulmonary VentilationSleep Apnea, ObstructiveSuperoxide DismutaseTime FactorsUbiquinoneVitamin EAntioxidantscoenzyme Q10Superoxide DismutaseUbiquinoneVitamin E

Identifiers

PMID19805747
PMCPMC2793876
OpenAlexW1531704029

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.